• Exercising with Scleroderma: The Paradox of My Enthusiasm
  • Galectin’s Candidate Therapy GR-MD-02 Patent Extended to Cover Several Illnesses Including Systemic Sclerosis
  • What It Feels Like to Look Rare
  • Rheumatologist Calls for More Screening of Scleroderma Patients for Pulmonary Hypertension
  • Week 3 Scleroderma Awareness Month 2017: Patient Profiles, Medical Research, Areas of Current Interest
  • Phase 2 Trial Results Presented of Corbus’ Anabasum as Treatment for Systemic Sclerosis
  • The Power of Encouragement Fuels Hope, Unity and Optimism
  • Two New Tools Presented at EULAR Congress Could Aid Early SSc Diagnosis
  • Week 2 Scleroderma Awareness Month: Patient Profiles 2017, Progress in Medical Research
  • Fibrocell’s FX-013 Therapy Wins FDA Rare Pediatric Disease Designation for Localized Scleroderma
  • Time to Add a Splash of Positive to My Half-Empty Glass
  • How Essential Oils Can Benefit Chronic Illness Sufferers